201
Views
24
CrossRef citations to date
0
Altmetric
Original Research

Cardiovascular Risk in Individuals with Inflammatory Bowel Disease

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 107-113 | Published online: 24 Apr 2020

References

  • Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J. Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol. 2011;27:174–182. doi:10.1016/j.cjca.2010.12.040
  • Singh S, Kullo IJ, Pardi DS, Loftus EV. Epidemiology, risk factors and management of cardiovascular diseases in IBD. Nat Rev Gastroenterol Hepatol. 2015;12:26–35. doi:10.1038/nrgastro.2014.202
  • Seminerio JL, Koutroubakis IE, Ramos-Rivers C, et al. Impact of obesity on the management and clinical course of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:2857–2863. doi:10.1097/MIB.0000000000000560
  • Moran GW, Dubeau MF, Kaplan GG, Panaccione R, Ghosh S. The increasing weight of Crohn’s disease subjects in clinical trials: a hypothesis-generatings time-trend analysis. Inflamm Bowel Dis. 2013;19:2949–2956. doi:10.1097/MIB.0b013e31829936a4
  • Ha C, Magowan S, Accortt NA, Chen J, Stone CD. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol. 2009;104:1445–1451. doi:10.1038/ajg.2009.81
  • Osterman MT, Yang YX, Brensinger C, Forde KA, Lichtenstein GR, Lewis JD. No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn’s disease. Clin Gastroenterol Hepatol. 2011;9:875–880. doi:10.1016/j.cgh.2011.06.032
  • Rungoe C, Basit S, Ranthe MF, Wohlfahrt J, Langholz E, Jess T. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study. Gut. 2013;62:689–694. doi:10.1136/gutjnl-2012-303285
  • American Heart Association. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease; 2019. Available from: https://www.ahajournals.org/doi/suppl/10.1161/CIR.0000000000000678. Accessed April 14, 2020.
  • Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal world congress of gastroenterology. Can J Gastroenterol. 2005;19:5A–36A. doi:10.1155/2005/269076
  • Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753. doi:10.1136/gut.2005.082909
  • Best WR, Becktel JM, Singleton JW, Jr KF. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology. 1976;70:439–444. doi:10.1016/S0016-5085(76)80163-1
  • Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625–1629. doi:10.1056/NEJM198712243172603
  • World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Geneva: WHO; 1998:8–9.
  • Organización Panamericana de la Salud (OPAS). XXXVI Reunión del Comitê Asesor de Investigaciones en Salud – Encuestra Multicêntrica – Salud Beinestar y Envejecimeiento (SABE) en América Latina e el Caribe – Informe preliminar; 2002 [XXXVI Meeting of the Advisory Committee on Health Research - Survey Multicenter - Health Well-being and Aging (SABE) in Latin America and the Caribbean – Preliminary report; 2002]. Spanish.
  • Touboul PG, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness consensus (2004–2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis. 2007;23:75–80. doi:10.1159/000097034
  • Gray-Weale AC, Graham JC, Burnett JR, Lusby RJ. Carotid artery atheroma: comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathology. J Cardiovasc Surg. 1988;29:676–681.
  • Stein JH, Korcarz CE, Hurst RT, et al; American Society of Echocardiography Carotid Intima-Media Thickness Task Force Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21:93–111. doi:10.1016/j.echo.2007.11.011
  • Salmazo PS, Bazan SGZ, Shiraishi FG, Bazan R, Okoshi K, Hueb JC. Frequency of subclinical atherosclerosis in Brazilian HIV-infected patients. Arq Bras Cardiol. 2018;110:402–410. doi:10.5935/abc.20180058
  • Singh S, Singh H, Loftus EV, Pardi DS. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:382–393. doi:10.1016/j.cgh.2013.08.023
  • Kristensen SL, Ahlehoff O, Lindhardsen J, et al. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death: a Danish nationwide cohort study. PLoS One. 2013;8:e56944. doi:10.1371/journal.pone.0056944
  • Anderson TJ, Grégoire J, Pearson GJ, et al. 2016 Canadian Cardiovascular Society Guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2016;32:1263–1282. doi:10.1016/j.cjca.2016.07.510
  • National Cholesterol Education Program (NCEP). Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III: final report). Circulation. 2002;106:3145–3146.
  • Sociedade Brasileira de Cardiologia. Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. IV Diretriz Brasileira Sobre Dislipidemias e Prevenção da Aterosclerose [IV Brazilian Guideline on Dyslipidemias and Atherosclerosis Prevention]. Arq Bras Cardiol. 2007;88:2–19. Portuguese. doi:10.1590/S0066-782X2007000700002
  • Rungoe C, Nynne AN, Jess T. Inflammatory bowel disease and risk of coronary heart disease. Trends Cardiovasc Med. 2015;25:699–704. doi:10.1016/j.tcm.2015.03.010
  • Gallino A, Aboyans V, Diehm C; European Society of Cardiology Working Group on Peripheral Circulation, et al. Non-coronary atherosclerosis. Eur Heart J. 2014;35:1112–1119. doi:10.1093/eurheartj/ehu071
  • Zaid M, Fujiyoshi A, Kadota A, Abbott RD, Miura K. Coronary artery calcium and carotid artery intima media thickness and plaque: clinical use in need of clarification. J Atheroscler Thromb. 2017;24:227–239. doi:10.5551/jat.RV16005
  • Nambi V, Chambless L, Folsom AR, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (atherosclerosis risk in communities) study. J Am Coll Cardiol. 2010;55:1600–1607. doi:10.1016/j.jacc.2009.11.075
  • Rundek T, Gardener H, Della-Morte D, et al. The relationship between carotid intima-media thickness and carotid plaque in the Northern Manhattan study. Atherosclerosis. 2015;241:364–370. doi:10.1016/j.atherosclerosis.2015.05.027
  • Simon A, Megnien JL, Chironi G. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol. 2010;30:182–185. doi:10.1161/ATVBAHA.109.196980
  • Steyers CM, Miller FJ Jr. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci. 2014;15:11324–11349. doi:10.3390/ijms150711324
  • Paschou SA, Kothonas F, Lafkas A, et al. Favorable effect of anti-TNF therapy on insulin sensitivity in nonobese, nondiabetic patients with inflammatory bowel disease. Int J Endocrinol. 2018;2018:6712901. doi:10.1155/2018/6712901